GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis

ConclusionsAmong patients with type 2 DM,  GLP-1R agonists are beneficial for primary stroke, MACE, and cardiovascular mortality prevention. Further RCTs are needed to evaluate their role for secondary stroke prevention.
Source: Journal of Neurology - Category: Neurology Source Type: research